Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102746338B reveals novel spiroketal ligands enabling high-selectivity hydroformylation. Discover cost-effective catalytic solutions for fine chemical manufacturing.
Patent CN117700326A reveals a novel Ruthenium catalyst for carbamate hydrogenation. This breakthrough enables cost reduction in fine chemical manufacturing and reliable supply chains.
Patent CN108774271A introduces stable ferrocene ligands for S-configuration alcohols. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN102276426A reveals a novel ligand-free Heck coupling method for trans-resveratrol. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116003467A reveals high-TON triphosphine ligands for olefin alkoxycarbonylation, enabling cost-effective pharma intermediate manufacturing.
Patent CN113999261B reveals a high-yield synthesis for ortho-dimethyl diphosphine ligands, offering cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN118619960A reveals ligand-assisted C-H activation for indole alkaloids, enhancing yield and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel copper-catalyzed desymmetrization method for high-purity chiral phosphine oxides. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply chain solutions.
Patent CN104478806A details a novel synthesis for phenyl bridged dipyrazolidine ligands offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106478721B details a metal-free chiral catalyst offering high enantioselectivity. Enhances supply chain reliability and reduces purification costs for pharmaceutical intermediates.
Novel C2 symmetric ligand enables high enantioselectivity in API intermediate manufacturing with improved stability and scalable synthesis routes.
Patent CN113429323A details a metal-free organocatalytic route for high-ee sulfonyl styrenes, offering cost-effective scalability for pharmaceutical intermediates.
Patent CN101395165A discloses a high-efficiency asymmetric ligand enabling cost reduction in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.
Patent CN102464672A discloses a novel mannitol-based ligand for asymmetric catalysis, offering high enantioselectivity and simplified synthesis for cost-effective pharmaceutical manufacturing.
Novel palladium-catalyzed method enables efficient deuteration without guiding groups, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Patent CN101519384A details a one-step synthesis of chiral oxazolines. Offers high enantioselectivity for asymmetric catalysis and scalable manufacturing solutions.
Novel 3-step route for Salan ligands via CN102786466A. High yield, mild conditions, scalable process for asymmetric catalysis applications.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.